Evidence map›Paper›PMID 28831442›Full record

ArticleJournal of global oncology2017

Cancer Care at Times of Crisis and War: The Syrian Example.

Eman Sahloul, Riad Salem, Wessam Alrez, Tayseer Alkarim, Ammar Sukari, Wasim Maziak, M Bassel Atassi

Abstract read
In one paragraph

Article in Journal of global oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eman Sahloul, Oakland University William Beaumont School of Medicine, Rochester; , Wayne State University, Detroit, MI; , Northwestern University, Chicago; , Little Company of Mary Hospital/Chicago Medical School, Evergreen Park, IL; , Alrahma Cancer Center, East Ghuta; , Medical Oncology, Damascus, Syria; and , Florida International University, Miami, FL.
Riad Salem, Oakland University William Beaumont School of Medicine, Rochester; , Wayne State University, Detroit, MI; , Northwestern University, Chicago; , Little Company of Mary Hospital/Chicago Medical School, Evergreen Park, IL; , Alrahma Cancer Center, East Ghuta; , Medical Oncology, Damascus, Syria; and , Florida International University, Miami, FL.
Wessam Alrez, Oakland University William Beaumont School of Medicine, Rochester; , Wayne State University, Detroit, MI; , Northwestern University, Chicago; , Little Company of Mary Hospital/Chicago Medical School, Evergreen Park, IL; , Alrahma Cancer Center, East Ghuta; , Medical Oncology, Damascus, Syria; and , Florida International University, Miami, FL.
Tayseer Alkarim, Oakland University William Beaumont School of Medicine, Rochester; , Wayne State University, Detroit, MI; , Northwestern University, Chicago; , Little Company of Mary Hospital/Chicago Medical School, Evergreen Park, IL; , Alrahma Cancer Center, East Ghuta; , Medical Oncology, Damascus, Syria; and , Florida International University, Miami, FL.
Ammar Sukari, Oakland University William Beaumont School of Medicine, Rochester; , Wayne State University, Detroit, MI; , Northwestern University, Chicago; , Little Company of Mary Hospital/Chicago Medical School, Evergreen Park, IL; , Alrahma Cancer Center, East Ghuta; , Medical Oncology, Damascus, Syria; and , Florida International University, Miami, FL.
Wasim Maziak, Oakland University William Beaumont School of Medicine, Rochester; , Wayne State University, Detroit, MI; , Northwestern University, Chicago; , Little Company of Mary Hospital/Chicago Medical School, Evergreen Park, IL; , Alrahma Cancer Center, East Ghuta; , Medical Oncology, Damascus, Syria; and , Florida International University, Miami, FL.
M Bassel Atassi, Oakland University William Beaumont School of Medicine, Rochester; , Wayne State University, Detroit, MI; , Northwestern University, Chicago; , Little Company of Mary Hospital/Chicago Medical School, Evergreen Park, IL; , Alrahma Cancer Center, East Ghuta; , Medical Oncology, Damascus, Syria; and , Florida International University, Miami, FL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs Syria enters its fifth year of conflict, the number of civilians killed and injured continues to rise sharply. Along with this conflict comes the rapid decline of medical care, specifically cancer care. To determine physician and equipment availability, cancer screening and management, and possible solutions relative to various major cities, a survey was distributed to physicians inside Syria through the help of the humanitarian organization Syrian American Medical Society.

methodsOnline surveys were distributed to both certified oncologists who work in cancer clinics and general physicians who work in rural and mobile clinics inside Syria. Variables assessed were physician specialty, location, population, cost, regional situation (besieged versus government controlled), and resource availability and access. Results were stratified by location and physician specialty.

resultsSurvey results revealed a large shortage of specialized physicians and inhibited accessibility to screening and management options in besieged areas compared with government-controlled regions. Physicians within both government-controlled and besieged cities reported limited or no targeted agents, radiation therapy, clinical trials, bone marrow transplantation, positron emission tomography scans, magnetic resonance imaging, and genetic testing.

conclusionThe Syrian civil war has resulted in suboptimal oncology care in the majority of the region. In consideration of specific deficiencies in cancer care, we recommend several solutions that may better the level of care in Syria: patient education on medical documentation and self-examination; online consultation; and cheap, effective screening methods. The implementation of these recommendations may change the course of cancer care in a country that has deteriorated into the worst humanitarian crisis of the century.

Identifiers

PMID28831442
PMCPMC5560458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.